Yahoo Web Search

Search results

    • Is This a Setback for Moderna?

      Is This a Setback for Moderna?

      Motley Fool via Yahoo Finance· 20 hours ago

      Investors have put their hopes in Moderna's (NASDAQ: MRNA) next potential product, a respiratory syncytial virus (RSV) vaccine. That's because it...

    • Is Viking Therapeutics the Best Biotech Stock for You?

      The Motley Fool via AOL· 2 days ago

      With that said, as a biotech, it's still on the riskier side of the investment spectrum. As good as its clinical trial data has been so far, there's always a risk that regulators< ...

    • Colliers declares semi-annual dividend

      Digital Journal· 8 hours ago

      Additional information and risk factors are identified in the Company’s other periodic filings with Canadian and US securities regulators (which factors are adopted herein ...